GovBidAlerts
← All opportunities

Norgestimate/Ethinyl Estradiol Tablets

Key dates

Posted
Mar 26, 2026
Response deadline
—
Archive date
—
Archive type
autocustom

Classification

Notice type
Award Notice
Base type
Award Notice
Set-aside
—
Set-aside code
—
PSC
6505

NAICS

  • 325412Pharmaceutical Preparation Manufacturing

    This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Cross-References. Establishments primarily engaged in--

Issuing office

Department
DEPT OF DEFENSE
Sub-tier
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Office code
—
Organization type
OFFICE
Office address
PHILADELPHIA, PA, 19111, USA

Place of performance

Street
—
Street 2
—
City
Villaquilambre
State
—
Zip
24193
Country
ESP

Contacts

Description

SPE2D2-25-D-0009 P00001 to exercise Option Year 1 effective April 27, 2026 through April 26, 2027. SPE2D2-25-D-0009 Norgestimate/Ethinyl Estradiol Tablets Award

Award

Number
SPE2D2-25-D-0009
Amount
$4,229,263.40
Date
—
Awardee
AVKARE LLC Pulaski TN 38478 USA
UEI
—
Awardee address
—

Other notices in this solicitation

Similar open contracts

Similar past awards

Metadata

Notice ID
f9d32774094d472fbda9c0ee00c176a6
Full path
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
Office code
—
Ingested
May 2, 2026
Updated
May 3, 2026
Raw record
{
  "CGAC": "097",
  "City": "PHILADELPHIA",
  "Link": "https://sam.gov/workspace/contract/opp/f9d32774094d472fbda9c0ee00c176a6/view",
  "Sol#": "SPE2D2-25-D-0009",
  "Type": "Award Notice",
  "State": "PA",
  "Title": "Norgestimate/Ethinyl Estradiol Tablets",
  "Active": "Yes",
  "Award$": "4229263.40",
  "Office": "DLA TROOP SUPPORT",
  "PopZip": "24193",
  "Awardee": "AVKARE LLC Pulaski TN 38478 USA",
  "PopCity": "Villaquilambre",
  "ZipCode": "19111",
  "AAC Code": "SPE2D2",
  "BaseType": "Award Notice",
  "NoticeId": "f9d32774094d472fbda9c0ee00c176a6",
  "PopState": "",
  "SetASide": "",
  "Sub-Tier": "DEFENSE LOGISTICS AGENCY",
  "AwardDate": "2025-04-27",
  "FPDS Code": "97AS",
  "NaicsCode": "325412",
  "PopCountry": "ESP",
  "PostedDate": "2026-03-26 11:22:58.44-04",
  "ArchiveDate": "2030-04-26",
  "ArchiveType": "autocustom",
  "AwardNumber": "SPE2D2-25-D-0009",
  "CountryCode": "USA",
  "Description": "SPE2D2-25-D-0009 P00001 to exercise Option Year 1 effective April 27, 2026 through April 26, 2027. SPE2D2-25-D-0009 Norgestimate/Ethinyl Estradiol Tablets Award",
  "SetASideCode": "",
  "OrganizationType": "OFFICE",
  "PopStreetAddress": "",
  "ResponseDeadLine": "",
  "PrimaryContactFax": "",
  "AdditionalInfoLink": "",
  "ClassificationCode": "6505",
  "PrimaryContactEmail": "kyle.lewicki@dla.mil",
  "PrimaryContactPhone": "4457370977",
  "PrimaryContactTitle": "",
  "SecondaryContactFax": "",
  "Department/Ind.Agency": "DEPT OF DEFENSE",
  "SecondaryContactEmail": "jason.wray@dla.mil",
  "SecondaryContactPhone": "4457376304",
  "SecondaryContactTitle": "",
  "PrimaryContactFullname": "Kyle Lewicki",
  "SecondaryContactFullname": "Jason Wray"
}